nivolumab,ipilimumab
bms
[' ovation']
pd-1 plus ctla-4 blockade in mismatch repair-deficient (dmmr) colon cancer with the best waterfall plot you ll ever see. 'striking' colon cancer data spur mid-presentation ovation at esmo 
Long-time small-cap biotech investor & entrepreneur - currently co-founder of biotech startup. Perennial loser in New Yorker caption contest.